Soft Tissue Allograft Market is Expected to Reach USD 5.5 Billion by 2027


Global Soft Tissue Allograft Market is expected to grow at high-rate due to rise in disposable income, growing awareness regarding allograft procedures, rising incidences of soft tissue injuries, and increasing aging populations. The Global Soft Tissue Allograft Market was valued at USD 3.6 Bn in 2020 and is expected to reach USD 5.5 Bn by 2027, with a growing CAGR of 6.4% during the forecast period (2017-2027).

The driving factors influencing the growth of global soft tissue allograft market include increase in tissue replacement procedures, aging populations, and rising demand for minimal invasive surgical procedures. Moreover, increase in accident rates, rising dental diseases, increase in consumption of alcohol and smoking that causes enamel decaying and increasing obese population fuels the growth of soft tissue allograft market.

In addition to this, increasing active participations in athletic activities, rising awareness regarding allografting and increasing application of soft tissue allograft in healthcare further leverage the growth of soft tissue allograft market.

Growing government support for research and development process, increasing interest of pharmaceutical and biopharmaceutical companies in allografts and rising healthcare expenditure uplifts the growth of soft tissue allograft market. On the contrary, lack of substitutes for tissue repair, poor reimbursement policies and prohibitive cost of treatment hinders the growth of soft tissue allograft market.

This soft tissue allograft market is broadly segmented into type, application, end user and region. Based on type, cartilage allograft segment held largest market share in 2020 and is expected to increase more during the forecast period. Based on application, orthopaedic segment accounted for the highest market share in 2020 and is expected to increase during the forecast period due to increasing rate of accidents.

Based on end user, hospital held maximum market share in 2020 due to availability of complete patient health monitoring at one place. Geographically, North America region dominated the soft tissue allograft market due to availability of large volume of aging patients and enormous presence of healthcare infrastructure.

The covid-19 outbreak has impacted the growth of soft tissue allograft market as there was restrictions on public mobility which impacted the demand for surgical and therapeutic procedures. Sudden covid-19 outbreak build pressure on healthcare centers and hospitals are providing services to covid infected patients. This factor impedes the growth of end user sector in soft tissue allograft market.

Global Soft Tissue Allograft Market by Region Outlook (Revenue, USD Million, 2021-2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on region, North America dominated the growth of soft tissue allograft market due to availability of huge healthcare infrastructure and presence of large volume of geriatric population. Moreover, availability of key market players in this region, increasing demand for orthopaedic soft tissue repair procedures and tissue regeneration further leverage the growth of soft tissue allograft market. In addition to this, increasing research in tissue regeneration and repair uplifts the growth of soft tissue allograft market.

However, Asia-Pacific is expected to witness the fastest market growth with the highest CAGR due to ongoing research on soft tissue repair and availability of technological advances that boost the growth of soft tissue allograft market.

The Global Soft Tissue Allograft Market Segmentation:

Global Soft Tissue Allograft Market by Type Outlook (Revenue, USD Million, 2021-2027)

  • Meniscus Allograft
  • Cartilage Allograft
  • Tendon Allograft
  • Dental Allograft
  • Others

Global Soft Tissue Allograft Market by Application Outlook (Revenue, USD Million, 2021-2027)

  • Dentistry
  • Orthopaedic
  • Wound Care
  • Others

Global Soft Tissue Allograft Market by End User Type Outlook (Revenue, USD Million, 2021-2027)

  • Aesthetic Centres
  • Dental Clinics
  • Orthopaedic Clinic
  • Hospitals
  • Others

Key Findings:

  • Based on type, cartilage allograft accounted for the highest market share in 2020 and is expected to increase during forecast period.
  • Based on application, orthopaedic segment held the largest market share in 2020 and is expected to increase during forecast period due increase in orthopaedic surgeries.
  • Based on end user, hospital segment held maximum market share in 2020 and is expected to increase more during forecast period due to increase in number of patient admission.
  • Based on region, North America is expected to dominate the soft tissue allograft market due to presence of substantial number of key players. However, the Asia-Pacific market is projected to witness fastest growth during forecast period.

Company Profiles and Competitive Intelligence

The key players operating in the soft tissue allograft market are:

  • Lattice Biologics Ltd.
  • AlonSource Group
  • CONMED Corporation
  • Zimmer Biomet
  • MiMedix Group
  • AlloSource
  • Osiris Therapeutics
  • Organogenesis, Inc.
  • RTI Surgical, Inc.
  • Integra LifeSciences Corporation
  • Alliqua BioMedical, Inc.
  • Globus Medical, Inc.
  • Straumann Holding AG
  • Arthrex.
  • Xtant Medical
  • Abbvie inc.
  • Smith & Nephew
  • Becton Dickinson and Company,
  • Integra LifeSciences Corporation,
  • Stryker Corporation,
  • Direct Biologics
  • C. R. Bard, Inc. (Davol, Inc.)
  • B. Braun Melsungen

Recent News:

  • In February 2020, Integra LifeSciences launched AmnioExcel Plus Placental Allograft Membrane for wound care to support soft tissue repair. AmnioExcel prove to be the powerful addition to their comprehensive and clinical product portfolio to treat wounds and improve patient outcome.
  • In August 2021, AlloSource launched AlloMend, an ultra-thick acellular dermal matrix is considered as newest addition to the AlloMend product line. The product is designed to replace or repair damage tissue.  

Quick Inquiry

Follow Us